Publications by authors named "B Eghtesad"

Article Synopsis
  • The study focuses on a surgical technique to address venous thrombosis that can occur after uterus transplantation (UTx), which is a treatment for uterine factor infertility.
  • A case report describes the successful intervention in a 30-year-old woman who developed intraoperative thrombosis after receiving a uterus from a brain-dead donor.
  • The innovative "Y-shaped" venous jump graft restored venous outflow, leading to a successful pregnancy and the delivery of a healthy infant, marking a significant advancement in UTx procedures.
View Article and Find Full Text PDF

Background: This study compares selection criteria for liver transplant (LT) for hepatocellular carcinoma (HCC) for inclusivity and predictive ability to identify the most permissive criteria that maintain patient outcomes.

Methods: The Scientific Registry of Transplant Recipients (SRTR) database was queried for deceased donor LT's for HCC (2003-2020) with 3-y follow-up; these data were compared with a 2-center experience. Milan, University of California, San Francisco (UCSF), 5-5-500, Up-to-seven (U7), HALT-HCC, and Metroticket 2.

View Article and Find Full Text PDF

Background: Solid organ transplant recipients (SOTRs) are at high risk for severe COVID-19.

Methods: This open-label, phase 3b trial evaluated mRNA-1273 in 137 kidney and 77 liver SOTRs and 20 immunocompetent participants. In part A, SOTRs received three 100-µg doses of mRNA-1273; immunocompetent participants received 2 doses.

View Article and Find Full Text PDF

Background: Portal vein thrombosis is a potentially devastating complication following pediatric liver transplantation. In rare instances of complete portomesenteric thrombosis, cavoportal hemitransposition may provide graft inflow. Here we describe long-term results following a case of pediatric cavoportal hemitransposition during liver transplantation and review the current pediatric literature.

View Article and Find Full Text PDF

Background: Liver transplantation (LT) is a well-established treatment for hepatocellular carcinoma (HCC), but there are ongoing debates regarding outcomes and selection. This study examines the experience of LT for HCC at a high-volume centre.

Methods: A prospectively maintained database was used to identify HCC patients undergoing LT from 2000 to 2020 with more than or equal to 3-years follow-up.

View Article and Find Full Text PDF